Chemours (NYSE:CC) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Chemours (NYSE:CC) issued its quarterly earnings data on Monday. The specialty chemicals company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.05), FiscalAI reports. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.53 billion. Chemours had a negative net margin of 5.00% and a positive return on equity of 60.64%. The business’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the company posted $0.40 earnings per share.

Chemours Price Performance

NYSE CC opened at $13.20 on Tuesday. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of -6.91 and a beta of 1.41. Chemours has a 1-year low of $10.44 and a 1-year high of $28.67. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.66 and a quick ratio of 0.88. The business’s fifty day moving average price is $14.17 and its 200-day moving average price is $18.26.

Chemours Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 16th will be issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, November 16th. Chemours’s dividend payout ratio is presently -18.32%.

Chemours News Summary

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours launched its Faizeon™ two-phase liquid-cooling portfolio for AI, high-performance-computing and high-density data centers. The products are designed to manage rising heat loads while reducing energy and water consumption, offering a potential growth opportunity in data-center infrastructure. Chemours Launches Faizeon Two-Phase Liquid Cooling Solutions for AI Data Centers
• Neutral Sentiment: Third-quarter revenue of $1.54 billion slightly exceeded the $1.53 billion analyst consensus, suggesting demand was broadly in line with expectations. However, additional operating metrics highlighted by analysts may provide a more mixed view of segment performance. Here’s What Key Metrics Tell Us About Chemours Q3 Earnings
• Negative Sentiment: Chemours reported third-quarter adjusted EPS of $0.21, below the $0.27 consensus and down from $0.40 a year earlier. The company also posted a negative 5% net margin, reinforcing concerns about profitability and the earnings outlook. The Chemours Company Reports Third Quarter Results
• Negative Sentiment: Multiple law firms announced or promoted a securities class action alleging that Chemours made misleading statements between February 20 and August 4, 2026, particularly concerning Opteon aftermarket demand and the subsequent guidance cut. The lead-plaintiff deadline is December 7, 2026. Reports that UBS, Morgan Stanley and JPMorgan reduced price targets add to the negative sentiment. CC Shareholder Alert

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Mizuho downgraded Chemours from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $18.00 to $15.00 in a report on Wednesday, October 14th. Morgan Stanley set a $18.00 price objective on Chemours in a report on Monday, August 10th. Truist Financial dropped their target price on Chemours from $24.00 to $20.00 and set a “buy” rating on the stock in a report on Tuesday, October 20th. Royal Bank Of Canada cut Chemours from an “outperform” rating to a “sector perform” rating and set a $14.00 target price on the stock. in a research note on Tuesday, October 13th. Finally, BMO Capital Markets reduced their price target on Chemours from $26.00 to $18.00 and set an “outperform” rating for the company in a report on Thursday, August 13th. Three equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Chemours currently has an average rating of “Hold” and an average target price of $17.73.

Insider Buying and Selling

In other news, CEO Denise Dignam purchased 3,378 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was acquired at an average cost of $14.95 per share, for a total transaction of $50,501.10. Following the purchase, the chief executive officer directly owned 339,916 shares in the company, valued at $5,081,744.20. This trade represents a 1.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Calderon Gerardo Familiar bought 1,935 shares of the business’s stock in a transaction that occurred on Wednesday, August 12th. The shares were acquired at an average price of $15.53 per share, with a total value of $30,050.55. Following the completion of the transaction, the insider directly owned 58,547 shares of the company’s stock, valued at $909,234.91. This trade represents a 3.42% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 8,663 shares of company stock valued at $130,601 over the last 90 days. Company insiders own 0.85% of the company’s stock.

Chemours Company Profile

The Chemours Company (NYSE: CC) is a global chemistry company that develops and manufactures performance chemicals and advanced materials for industrial and consumer applications. The company serves customers in markets including automotive, construction, energy, electronics, healthcare, and general manufacturing.

Chemours operates through businesses focused on Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Its products include titanium dioxide pigments used to provide whiteness and opacity in coatings, plastics, and paper; refrigerants and related thermal-management solutions; and high-performance fluoropolymers and specialty materials sold under brands such as Teflon™, Viton™, and Nafion™.

Headquartered in Wilmington, Delaware, Chemours serves customers globally through manufacturing facilities, research and development operations, and commercial activities across North America, Latin America, Europe, and Asia-Pacific.